Margin assessment after neoadjuvant chemotherapy in invasive lobular cancer

American Journal of Surgery

Volumn 198, Issue 3, 2009, Pages 387-391

  Wagner, Jamie ^a   Boughey, Judy C ^a   Garrett, Betsy ^a   Babiera, Gildy ^a   Kuerer, Henry ^a   Meric Bernstam, Funda ^a   Singletary, Eva ^a   Hunt, Kelly K ^a   Middleton, Lavinia P ^a   Bedrosian, Isabelle ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Breast; Lobular cancer; Local recurrence; Margins; Neoadjuvant chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST CONSERVATION THERAPY; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SURGERY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INVASIVE LOBULAR CARCINOMA; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENCE RISK; REOPERATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, LOBULAR; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; REOPERATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 67349220534     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2009.01.006     Document Type: Article

References (19)

1. Tavassoli F.A. World Health Organization classification of tumours. Pathology and genetics: tumours of the breast and female genital organs (2003), IARC, The Oxford Press 23-26
2. BD. Feig B.W., and Fuhrman G.M. The MD Anderson surgical oncology handbook. 4th ed. (2006), Lippincott Williams Wilkins, Philadelphia, PA 23-59
3. Singletary S.E., Patel-Parekh L., and Bland K.I. Treatment trends in early-stage invasive lobular carcinoma: a report from the national cancer data base. Ann Surg 242 (2005) 281-289
4. Bouvet M., Ollila D.W., Hunt K.K., et al. Role of conservation therapy for invasive lobular carcinoma of the breast. Ann Surg Oncol 4 (1997) 650-654
5. Salvadori B., Biganzoli E., Veronesi P., et al. Conservative surgery for infiltrating lobular breast carcinoma. Br J Surg 84 (1997) 106-109
6. Peiro G., Bornstein B.A., Connolly J.L., et al. The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat 59 (2000) 49-54
7. Holland P.A., Shah A., Howell A., et al. Lobular carcinoma of the breast can be managed by breast-conserving therapy. Br J Surg 82 (1995) 1364-1366
8. Vo T.N., Meric-Bernstam F., Yi M., et al. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. Am J Surg 192 (2006) 552-555
9. Stolier A.J., Barre G., Bolton J.S., et al. Breast conservation therapy for invasive lobular carcinoma: the impact of lobular carcinoma in situ in the surgical specimen on local recurrence and axillary node status. Am Surg 70 (2004) 818-821
10. Ciocca R.M., Li T., Freedman G.M., et al. Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy. Ann Surg Oncol 15 (2008) 2263-2271
11. Cristofanilli M., Gonzalez-Angulo A., Sneige N., et al. Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol 23 (2005) 41-48
12. Cocquyt V.F., Blondeel P.N., Depypere H.T., et al. Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma. Eur J Surg Oncol 29 (2003) 361-367
13. Tubiana-Hulin M., Stevens D., Lasry S., et al. Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution. Ann Oncol 17 (2006) 1228-1233
14. Mai K.T., Yazdi H.M., and Isotalo P.A. Resection margin status in lumpectomy specimens of infiltrating lobular carcinoma. Breast Cancer Res Treat 60 (2000) 29-33
15. Moore M.M., Borossa G., Imbrie J.Z., et al. Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy. Ann Surg 231 (2000) 877-878
16. Dillon M.F., Hill A.D., Fleming F.J., et al. Identifying patients at risk of compromised margins following breast conservation for lobular carcinoma. Am J Surg 191 (2006) 201-205
17. van den Broek N., van der Sangen M.J., van de Poll-Franse L.V., et al. Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer. Breast Cancer Res Treat 105 (2007) 63-68
18. Schnitt S.J., Connolly J.L., Recht A., et al. Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy. Cancer 64 (1989) 448-454
19. Hussien M., Lioe T.F., Finnegan J., et al. Surgical treatment for invasive lobular carcinoma of the breast. Breast 12 (2003) 23-35